mbeck

Recognition grows for role of LNPs and Canadian biotech in COVID-19 mRNA-based vaccines

Since news of the Pfizer-BioNTech COVID-19 vaccine first broke in November 2020, growing recognition has been given to the Canadian nanomedicine-based component underlying the vaccine’s effectiveness: the lipid nanoparticle (LNP) delivery system that originated from basic research by NMIN Scientific Director Dr. Pieter Cullis that started over 40 years ago… Read More »Recognition grows for role of LNPs and Canadian biotech in COVID-19 mRNA-based vaccines

Transmucosal drug delivery & the model dilemma in biomedical research: Two new papers out of the Hedtrich Lab

Two new publications highlight recent research from the UBC-based lab of NMIN researcher Dr. Sarah Hedtrich. Transmucosal drug delivery The first, published 14 March 2021 in Small, describes the lab’s recent efforts to develop a method for efficient transmucosal drug delivery. “Mucosal surfaces pose a challenging environment for efficient drug… Read More »Transmucosal drug delivery & the model dilemma in biomedical research: Two new papers out of the Hedtrich Lab

Canada’s health security requires increased research support: Op-Ed by NMIN researchers

“Canada’s biomedical community can clearly be competitive globally. However, we need investment in research and development, as well as infrastructure, to enable end-to-end, made-in-Canada solutions that can help Canadians and ensure health security.” This is the key message of an opinion piece by NMIN research leaders Drs. Pieter Cullis and… Read More »Canada’s health security requires increased research support: Op-Ed by NMIN researchers

NMIN Researchers Drs. Christine Allen & Pieter Cullis receive Controlled Release Society awards

Two NMIN researchers were recently recognized with awards from the Controlled Release Society (CRS). Dr. Christine Allen was awarded the CRS 2021 Women in Science award acknowledging her international recognition for outstanding contributions in science and technology. Dr. Pieter Cullis was awarded the 2021 CRS Founders Award, acknowledging his international… Read More »NMIN Researchers Drs. Christine Allen & Pieter Cullis receive Controlled Release Society awards

NMIN researcher’s company develops new DNA-based COVID-19 vaccine

Edmonton-based company Entos Pharmaceuticals has developed a new DNA-based vaccine for COVID-19 that is expected to enter Phase 1 clinical trials soon. NMIN researcher Dr. John Lewis, associate professor of oncology at the University of Alberta, is CEO of Entos. At the outset of the pandemic, the company repurposed its… Read More »NMIN researcher’s company develops new DNA-based COVID-19 vaccine

NMIN’s Scientific Director changes course

Dr. Cullis stepping down as Scientific Director to pursue commercialization opportunities NMIN’s founding Scientific Director, Dr. Pieter Cullis, seizes yet another new opportunity. Over his celebrated career, he has spearheaded numerous innovations and created a range of new business opportunities for Canadians through his intrepid entrepreneurialism. Most recently, his aptitude… Read More »NMIN’s Scientific Director changes course

NMIN’s Scientific Director tells the story of the LNP delivery system behind Pfizer’s COVID-19 vaccine

In a January 15, 2021 seminar organized by the Life Sciences Institute of the University of British Columbia, NMIN’s Scientific Director Dr. Pieter Cullis shared a first-hand account of the 40-year scientific journey that culminated in the lipid nanoparticle (LNP) delivery system underpinning the Pfizer/BioNTech vaccine against COVID-19. Watch the… Read More »NMIN’s Scientific Director tells the story of the LNP delivery system behind Pfizer’s COVID-19 vaccine